We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01728363
Ages eligible for Study
up to 32 Weeks
Genders eligible for Study
Accepts Healthy Volunteers
Sufficient intravascular access
Suspected systemic infection or receiving 1 of the study drugs per standard of care
informed consent from legal guardian
history of allergic reaction to study drugs
urine output <0.5 mL/hr/kg over the prior 24 hours
serum creatinine >1.7 mg/dl
Any condition in investigator judgment precludes participation because it could affect participant safety
All locations for NCT01728363
United States (10)
University of FL
Gainesville, Florida, United States, 32610
UFL Health and Baptist
Jacksonville, Florida, United States, 32209
Atlanta, Georgia, United States, 30322
Indianapolis, Indiana, United States, 46202
Wichita, Kansas, United States, 67214
University of Louisville
Louisville, Kentucky, United States, 40202
Tufts Medical Center
Boston, Massachusetts, United States, 02111
Kings County Hospital Center
Brooklyn, New York, United States, 11203
Durham, North Carolina, United States, 27705
University of Texas Children's Hospital
Galveston, Texas, United States, 77555
View full eligibility
Tris trial is registered with FDA with number: NCT01728363. The sponsor of the trial is Phillip Brian Smith and it is looking for 63 volunteers for the current phase. Official trial title: Pharmacokinetics of Antistaphylococcal Antibiotics in Infants
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!